November 22, 2026
Business

Mankind Pharma Q4 PAT rises 30% on strong domestic biz, chronic push(Soban News)

Mankind Pharma posted a 30.4% rise in Q4FY26 profit, driven by strong demand for chronic therapies and OTC healthcare products

​Mankind Pharma posted a 30.4% rise in Q4FY26 profit, driven by strong demand for chronic therapies and OTC healthcare products by Soban News (international And National News)

Related posts

Potential impacts of climate interventions on marine ecosystems – ESS Open Archive(Soban News)

News-Soban-Admin

Does Trump’s $100,000 H-1B visa fee hike impact Infosys? Here’s what CEO Salil Parekh says — ‘We reached out to…’(Soban News)

News-Soban-Admin

Nubank Sees Credit Growth Continuing as Quality Gauges Hold Up

News-Soban-Admin

Leave a Comment